Switch to Health Care Professionals
Email Page
Print PageRituxan Access Solutions—Committed to Helping You Access Rituxan (rituximab)
- Useful Links
- Forms and Documents
Understanding how to access and pay for your medication can be challenging. Rituxan Access Solutions is here to help you understand your options and the process.
Coverage and Reimbursement
Patient Assistance
Health insurance issues can be challenging. Rituxan Access Solutions is here to make the process as easy as possible. To learn more about our patient assistance programs, please click on the button that applies to you.
- I’m uninsured or my health insurance denied my coverage
- I have health insurance and need help with my co-pay*
- I have private health insurance and want to learn more about the Rituxan co-pay card
Informational Resources
We all know it’s important to have the right information at your fingertips. With this in mind, we’ve compiled a list of informational resources you may find useful.
Rituxan (Rituximab) INDICATIONS AND USAGE
Rheumatoid Arthritis
Rituxan is a prescription medication used to treat Rheumatoid Arthritis (RA) with another prescription medicine called methotrexate, to reduce the signs and symptoms of moderate to severe active RA in adults, after treatment with at least one other medicine called a Tumor Necrosis Factor (TNF) antagonist has been used and did not work well enough.
People with serious infections should not receive Rituxan.
Rituxan Boxed WARNINGS and Additional Important Safety Information
The most important serious adverse reactions of Rituxan are fatal infusion reactions, tumor lysis syndrome (TLS), severe mucocutaneous reactions, progressive multifocal leukoencephalopathy (PML), hepatitis B reactivation with fulminant hepatitis, other viral infections, cardiovascular events, renal toxicity, and bowel obstruction and perforation. The most common adverse reactions of Rituxan (incidence ≥25%) observed in patients with NHL are infusion reactions, fever, chills, infection, asthenia, and lymphopenia. The most common adverse reactions of Rituxan observed in patients with RA are hypertension, nausea, upper respiratory tract infection, arthralgia, pruritus, and pyrexia.
Attention healthcare provider: Provide Medication Guide to patient prior to Rituxan infusion.
For additional safety information, please see the full prescribing information, including Boxed WARNINGS and Medication Guide.
*Co-pay refers to a cost-sharing arrangement in which members of health insurance plans pay a specified charge for a product or service, such as a prescription or an office visit. Members are typically responsible for this payment at the time of service.
Privacy information: Any information submitted to Rituxan Access Solutions will remain confidential and will not be used for promotional purposes.
If you would like to learn more about protecting the privacy of personal health information, please go to the U.S. Department of Health & Human Services website at www.hhs.gov/ocr/hipaa/.
